These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2670343)

  • 41. Assessment of dried blood spot samples as a simple method for detection of hepatitis B virus markers.
    Villar LM; de Oliveira JC; Cruz HM; Yoshida CF; Lampe E; Lewis-Ximenez LL
    J Med Virol; 2011 Sep; 83(9):1522-9. PubMed ID: 21739441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of hepatitis B among pregnant women assisted at the public maternity hospitals of São Luís, Maranhão, Brazil.
    Souza MT; Pinho TL; Santos MD; Santos Ad; Monteiro VL; Fonsêca LM; Ferreira PA; Ferreira Ade S
    Braz J Infect Dis; 2012; 16(6):517-20. PubMed ID: 23168305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
    Chongsrisawat V; Thawornsuk N; Theamboonlers A; Louisirirotchanakul S; Poovorawan Y
    Viral Immunol; 2006; 19(4):623-9. PubMed ID: 17201657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
    van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
    Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Profiles of serological markers of HBV-infection in acute hepatitis B].
    Nikiforov ND; Sanin BI; Nikiforova GS; Saiapina ES; Novikova LV; Il'inskii IA; Popov AF
    Klin Med (Mosk); 1996; 74(7):16-8. PubMed ID: 8992103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancer.
    Levaggi A; De Maria A; Dozin B; Iacono G; Bighin C; Giraudi S; Lambertini M; D'Alonzo A; Poggio F; Pronzato P; Del Mastro L
    Anticancer Res; 2014 Jul; 34(7):3715-20. PubMed ID: 24982392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The incidence of detecting HB viral infection in the families of patients with kidney diseases].
    Dlin V; Ignatova MS; Asratian AA; Vasil'eva VI; Reĭzis AR; Klimanskaia EV; Viduta OD; Aprosina ZG; Ignatova TM; Drozd TN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):66-71. PubMed ID: 8059576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing scene in hepatitis B serology interpretation.
    Chan HL
    Hosp Med; 2002 Jan; 63(1):16-9. PubMed ID: 11828810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse seroconversion of hepatitis B in a haemodialysis patient.
    Freudiger H; Sitavanc R
    Nephrol Dial Transplant; 2004 Jan; 19(1):238-41. PubMed ID: 14671065
    [No Abstract]   [Full Text] [Related]  

  • 51. [The problems of viral hepatitis B in hemodialysis units].
    Nazarov ShN; Akalaev RN; Aripkhodzhaeva FA; Mirkamalov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (2):71-4. PubMed ID: 8059578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Automated Diagnosis of Hepatitis B Using Multilayer Mamdani Fuzzy Inference System.
    Ahmad G; Khan MA; Abbas S; Athar A; Khan BS; Aslam MS
    J Healthc Eng; 2019; 2019():6361318. PubMed ID: 30867895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunofluorescent test for the detection of anti-HBc.
    Madaliński K; Budkowska A; Michalak T; Trepo C
    Bibl Haematol; 1976; 42():65-70. PubMed ID: 786265
    [No Abstract]   [Full Text] [Related]  

  • 54. [Evaluation on Hepatitis B surveillance models at surveillance pilot points in China, 2013-2015].
    Miao N; Wang FZ; Zhang LJ; Zheng H; Sun XJ; Wang F; Zhang GM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1645-1648. PubMed ID: 29294580
    [No Abstract]   [Full Text] [Related]  

  • 55. [The effect of the acetylation phenotype on the course severity and outcome of acute viral hepatitis B].
    Usmanova LP; Kasimova NB; Kuznetsova TA; Kotel'nikova LI; Bogdanova AG; Cherenova OP
    Ter Arkh; 1996; 68(11):19-20. PubMed ID: 9045369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The results of an intensified examination of epidemiologically dangerous blood donors].
    Maslova IA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):117-9. PubMed ID: 7879504
    [No Abstract]   [Full Text] [Related]  

  • 57. Acute hepatitis and erythropoiesis in chronically haemodialyzed patients.
    Brunois JP; Lavaud S; Melin JP; Diebold M; Toupance O; Chanard J
    Nephron; 1981; 28(3):152-3. PubMed ID: 7301000
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum tumor necrosis factor in acute and fulminant hepatitis B.
    Cacopardo B; Fatuzzo F; Russo R; Celesia BM; La Rosa R; Lupo G; Cosentino S; Nunnari A
    J Infect Dis; 1992 Aug; 166(2):448-9. PubMed ID: 1634817
    [No Abstract]   [Full Text] [Related]  

  • 59. Interpreting hepatitis B serology.
    Loh K; Kew S
    Malays Fam Physician; 2007; 2(1):31-2. PubMed ID: 25606076
    [No Abstract]   [Full Text] [Related]  

  • 60. Serology of acute and chronic type B hepatitis.
    Rogers M; Davis GL
    Dig Dis; 1989; 7(5):255-64. PubMed ID: 2670343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.